Belvedere Trading LLC - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 28 filers reported holding BRIACELL THERAPEUTICS CORP in Q4 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
Belvedere Trading LLC ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q2 2023$128,028
-30.2%
15,388
-15.9%
0.00%
Q1 2023$183,549
+11.7%
18,300
-51.3%
0.00%
Q4 2022$164,312
-43.9%
37,600
-20.2%
0.00%
-100.0%
Q2 2022$293,000
+110.8%
47,100
+166.1%
0.01%
+125.0%
Q1 2022$139,000
-71.7%
17,700
-74.2%
0.00%
-81.8%
Q4 2021$491,000
+358.9%
68,600
+404.1%
0.02%
+633.3%
Q3 2021$107,00013,6080.00%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
Redmond Asset Management, LLC 131,731$508,0000.16%
SABBY MANAGEMENT, LLC 160,182$618,0000.12%
ZEKE CAPITAL ADVISORS, LLC 45,000$174,0000.01%
Freedom Investment Management, Inc. 16,339$63,0000.01%
Virtu Financial LLC 15,121$58,0000.00%
TORONTO DOMINION BANK 12$00.00%
ROYAL BANK OF CANADA 17$00.00%
UBS Group AG 632$2,0000.00%
OSAIC HOLDINGS, INC. 6,012$23,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders